Revolution MD Inc.

Over 100,000 people died from opioid overdoses between April 2020 to April 2021.* Revolution MD is developing a patent-pending smart inhaler designed to safely control the dispensing of opioids, providing immediate pain relief while minimizing the risk of addiction. Our Inhale device prevents abuse, addiction, and overdose by using real-time identity verification and communicating with prescribing physicians to ensure compliance. Become part of the solution and help us save countless lives by investing in Revolution MD’s blockchain-based technology. We’re ready to revolutionize the delivery of medication worldwide.** Contact us for more information at josh.kimmel@rev-md.com

Website

http://www.rev-md.com

External link for Revolution MD Inc.

Industry

Biotechnology

Company size

2-10 employees

Headquarters

Knoxville, Tennessee

Type

Privately Held

Founded

2019

Specialties

opioid dependence, opioid administration, opioid overdose, medical device, blockchain, analytics, artificial intelligence, AI, and IOT